Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
6
60%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (22.2%)
Phase 41 (11.1%)
N/A6 (66.7%)

Trials by Status

completed660%
unknown220%
recruiting110%
not_yet_recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10